Comparison of retropubic midurethral slings in the treatment of female stress urinary incontinence.

Over 50 different types of midurethral slings have been marketed. They have generally been considered comparable in performance. Many studies have compared retropubic with obturator slings, but few have compared different makes of retropubic slings with each other. We have compared the performance of retropubic slings using data from the Norwegian Female Incontinence Registry.

From June 2015 through 2017, 2843 women underwent a retropubic sling procedure, with 6-12-month follow-up data available for 2612 (92%). Results for six different types of slings used in this time period are presented: TVT Exact, TVT Classic, Advantage, Advantage Fit, TVT A.M.I. and RetroArc. The TVT Exact was the most prevalent sling, and the outcomes were compared with this sling as reference using chi-square and Dunnet's tests with significance at 0.05.

There were only small differences among the four slings, TVT Exact, TVT Classic, Advantage and Advantage Fit, with subjective cure rates from 77.7 to 81.9% and objective cure rates from 90.8 to 96.6%. The TVT A.M.I. sling had a high cure rate but significantly fewer satisfied patients and less improvement in urgency bother. The Retro Arc's results were clearly inferior. There was little difference in terms of obstruction or de novo urgency incontinence among the six slings. Most complication rates were not statistically different.

At 6-12-month follow-up there was no significant difference in clinical results between the TVT Exact, TVT Classic, Advantage and Advantage Fit slings, while RetroArc and to some extent TVT A.M.I. slings underperformed.

International urogynecology journal. 2019 Aug 13 [Epub ahead of print]

Hjalmar A Schiøtz, Rune Svenningsen, Sigurd Kulseng-Hanssen

Department of Obstetrics and Gynecology, Vestfold Hospital Trust, PO Box 2168, 3103, Tønsberg, Norway. ., Department of Gynecology, Oslo University Hospital, Ullevål, Oslo, Norway., The Norwegian Female Incontinence Registry, Oslo University Hospital, Ullevål, Oslo, Norway.